Evofem Biosciences Inc
General ticker "EVFM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $934.3K
Evofem Biosciences Inc does not follow the US Stock Market performance with the rate: -32.9%.
Estimated limits based on current volatility of 6.7%: low 0.01$, high 0.01$
Short-term EVFM quotes
Long-term EVFM plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $8.24MM | $16.84MM | $18.22MM |
| Operating Expenses | $175.04MM | $100.96MM | $36.06MM |
| Operating Income | $-166.80MM | $-84.12MM | $-17.85MM |
| Non-Operating Income | $-38.37MM | $7.47MM | $70.84MM |
| R&D Expense | $33.13MM | $25.03MM | $2.94MM |
| Income(Loss) | $-205.18MM | $-76.65MM | $53.00MM |
| Taxes | $0.02MM | $0.04MM | $0.02MM |
| Profit(Loss) | $-205.19MM | $-76.70MM | $52.98MM |
| Stockholders Equity | $-104.31MM | $-71.80MM | $-61.92MM |
| Inventory | $7.67MM | $5.38MM | $1.70MM |
| Assets | $42.51MM | $25.16MM | $10.55MM |
| Operating Cash Flow | $-146.67MM | $-70.41MM | $-8.97MM |
| Capital expenditure | $2.94MM | $0.34MM | $0.00MM |
| Investing Cash Flow | $-2.69MM | $-0.34MM | $-0.00MM |
| Financing Cash Flow | $90.69MM | $61.94MM | $4.78MM |
| Earnings Per Share* | $-2,931.31 | $-163.19 | $10.35 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.